Literature DB >> 12231601

Effect of load alterations on the effective regurgitant orifice area in chronic aortic regurgitation.

Y J Kim1, M Jones, T Shiota, H Tsujino, J X Qin, F Bauer, M Sitges, J Kwan, L A Cardon, A D Zetts, J D Thomas.   

Abstract

OBJECTIVE: To evaluate the load dependence of effective regurgitant orifice area (ROA) in an animal model of chronic aortic regurgitation.
METHODS: Eight sheep were studied 10-20 weeks after the surgical creation of aortic regurgitation. After baseline studies, 500 ml of blood, angiotensin II, and nitroprusside were infused sequentially. Electromagnetic flow meters were used as reference standards to determine aortic regurgitation volume. The time-velocity integral was acquired using the continuous wave Doppler method.
RESULTS: Baseline aortic regurgitant volume varied from 8 ml (regurgitant fraction 28%) to 29 ml (59%), with a mean (SD) value of 17 (8) ml; mean ROA was 0.15 (0.05) cm2. During angiotensin II infusion, aortic regurgitation volume (20 (8) ml) and mean diastolic aortoventricular pressure gradient (62 (18) mm Hg) increased by 26 (16)% and 48 (64)%, respectively (p < 0.01 for both). ROA did not change (0.16 (0.06) cm(2), p = 0.15). During nitroprusside infusion, aortic regurgitant volume (13 (7) ml, p = 0.05) and diastolic pressure gradient (25 (13) mm Hg, p < 0.05) decreased. ROA did not change (0.15 (0.05) cm2). When analysing 32 stages together, aortic regurgitant volume (r = 0.78, p < 0.01) and regurgitant fraction (r = 0.55, p < 0.01) correlated well with ROA. However, diastolic pressure gradient (r = 0.28) was not significantly correlated with ROA.
CONCLUSIONS: In an animal model of chronic aortic regurgitation, ROA did not change with load alterations.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2002        PMID: 12231601      PMCID: PMC1767378          DOI: 10.1136/heart.88.4.397

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  20 in total

1.  Mechanisms of aortic valve incompetence: finite element modeling of aortic root dilatation.

Authors:  K J Grande; R P Cochran; P G Reinhall; K S Kunzelman
Journal:  Ann Thorac Surg       Date:  2000-06       Impact factor: 4.330

2.  Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume.

Authors:  R R Miller; L A Vismara; A N DeMaria; A F Salel; D T Mason
Journal:  Am J Cardiol       Date:  1976-11-04       Impact factor: 2.778

3.  When should Doppler-determined valve area be better than the Gorlin formula?: Variation in hydraulic constants in low flow states.

Authors:  J Segal; D J Lerner; D C Miller; R S Mitchell; E A Alderman; R L Popp
Journal:  J Am Coll Cardiol       Date:  1987-06       Impact factor: 24.094

4.  Mechanical properties of the ascending thoracic aorta of man.

Authors:  E R Gozna; A E Marble; A J Shaw; D A Winter
Journal:  Cardiovasc Res       Date:  1973-03       Impact factor: 10.787

Review 5.  Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves.

Authors:  H J Levine; W H Gaasch
Journal:  J Am Coll Cardiol       Date:  1996-11-01       Impact factor: 24.094

6.  Effective regurgitant orifice area by the color Doppler flow convergence method for evaluating the severity of chronic aortic regurgitation. An animal study.

Authors:  T Shiota; M Jones; I Yamada; R S Heinrich; M Ishii; B Sinclair; S Holcomb; A P Yoganathan; D J Sahn
Journal:  Circulation       Date:  1996-02-01       Impact factor: 29.690

7.  The cyclic changes and structure of the base of the aortic valve.

Authors:  M Thubrikar; S P Nolan; L P Bosher; J D Deck
Journal:  Am Heart J       Date:  1980-02       Impact factor: 4.749

8.  Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation.

Authors:  J L Bolen; E L Alderman
Journal:  Circulation       Date:  1976-05       Impact factor: 29.690

9.  Captopril mediated decrease of aortic regurgitation.

Authors:  S N Reske; I Heck; J Kropp; H Mattern; R Ledda; R Knopp; C Winkler
Journal:  Br Heart J       Date:  1985-10

10.  Mechanism of reduction of mitral regurgitation with vasodilator therapy.

Authors:  C Yoran; E L Yellin; R M Becker; S Gabbay; R W Frater; E H Sonnenblick
Journal:  Am J Cardiol       Date:  1979-04       Impact factor: 2.778

View more
  1 in total

1.  Role of vasodilators in regurgitant valve disease.

Authors:  Artur Evangelista; Pilar Tornos; Antonia Sambola; Gaieta Permayer-Miralda
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.